In Finland, the imaging infrastructure is highly developed, serving the needs of research from cells to humans. Finnish imaging expertise focuses on cardiovascular diseases, metabolic and inflammation diseases, brain diseases and cancer research.
Finnish actors leading the way in the development of imaging include:
- Turku BioImaging consortium, including Turku PET Centre
- Biomedical Imaging Unit (BIU) and the National Bio-NMR Facility in Kuopio
- BioMag Laboratory in Helsinki and the Helsinki Medical Imaging Center
The development of a new PET method at the Turku PET Centre is an example of an industrial collaboration project. The method is used to visualize neurokinin-1 (NK1) receptor occupancy in order to study a new drug candidate targeted at NK1 in the human brain. This enables the examination of the effect of this new antagonist at various dose levels and an assessment of its efficacy and optimal dosing.
Another case is Nexstim Oy’s Navigated Brain Stimulation (NBS), the first non-invasive direct technique for the functional mapping of the motor cortex using a transcranial magnetic stimulation (TMS) guided by a standard MR image data.
Additional examples of Finnish imaging research include the use of hybrid imaging devices for visualizing vulnerable coronary artery plaques. New methods have also been developed for the imaging of pancreatic islands and brown adipose tissue.
Brain imaging research focuses on degenerative diseases, such as Parkinson’s and Alzheimer’s diseases, as well as on multiple sclerosis.
In the future, Finnish imaging expertise will focus on the development of new diagnostic imaging methods for cardiovascular, metabolic and brain diseases and on new imaging technologies, such as novel hybrid imaging systems.
The following links include some examples of organizations with imaging expertise in Finland:
GE Healthcare Finland Oy
Helsinki Medical Imaging Center
Philips Healthcare Finland Oy
Turku PET Centre
VTT – Technical Research Centre of Finland